Literature DB >> 32790821

The contribution of plasma uric acid to the risk of stroke in hypertensive populations.

Jing Shi1, Guanyun Yan2, Liming Cao1, Xue Li1, Yiwei Zhang1, Suhua Zhao1, Changyi Wang3, Jianping Ma3, Xiaolin Peng3, Hongen Chen3, Fulan Hu4, Ran Wang5.   

Abstract

BACKGROUND: There is limited available evidence of a relationship between uric acid (UA) level and stroke in hypertensive populations worldwide. We aimed to estimate the relationship between UA level and stroke in Chinese hypertensive populations.
METHODS: A total of 4 710 essentially hypertensive Chinese patients, including 307 with stroke, were recruited consecutively by cluster sampling from 60 communities in Shenzhen from April 2010 to September 2011. Demographic characteristics, UA level and stroke diagnosis were collected from every participant. Logistic regression analysis was used to estimate the association between UA level and stroke.
RESULTS: The study population comprised 2 361 females and 2 349 males, with a mean age of 58 ± 11.75 years. There were significant associations between UA level and stroke and ischaemic stroke (IS) risk for females in the crude model (M0), model 1 (M1) and model 2 (M2), with increasing odds ratios (OR) as the quartiles (Q) increased. The odds of stroke risk was highest in Q4 in M2 (UA > 396 µmol/l, OR: 3.05, 95% CI: 1.74-5.36 and OR: 3.19, 95% CI: 1.74-5.85), but not for males in M0, M1 and M2. A significant dose-response relationship existed between UA level and stroke, and between UA level and IS for females but not for males. Hyperuricaemia (HU) was also significantly associated with stroke and IS for females but not for males. Taking negative uric acid, homocysteine, triglycerides, total cholesterol and low-density lipoprotein cholesterol (UA-Hcy-TG-TC-LDL-C-) as the reference, the combinations of UA+Hcy+TG-TC-LDL-, UA+Hcy+TG+TC+LDL-C- and UA+Hcy+TG+TC+LDL-C+ were significantly associated with the risk of stroke for females (OR = 2.48, 7.85 and 3.04).
CONCLUSIONS: High UA level could significantly increase stroke risk in female hypertensive patients. Female hypertensive patients may benefit from managing UA at normal levels for stroke prevention.

Entities:  

Keywords:  haemorrhagic stroke; hypertension; hyperuricaemia; ischaemic stroke; stroke; uric acid

Mesh:

Substances:

Year:  2020        PMID: 32790821      PMCID: PMC8762791          DOI: 10.5830/CVJA-2020-023

Source DB:  PubMed          Journal:  Cardiovasc J Afr        ISSN: 1015-9657            Impact factor:   1.167


  42 in total

1.  Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.

Authors:  Martin J O'Donnell; Siu Lim Chin; Sumathy Rangarajan; Denis Xavier; Lisheng Liu; Hongye Zhang; Purnima Rao-Melacini; Xiaohe Zhang; Prem Pais; Steven Agapay; Patricio Lopez-Jaramillo; Albertino Damasceno; Peter Langhorne; Matthew J McQueen; Annika Rosengren; Mahshid Dehghan; Graeme J Hankey; Antonio L Dans; Ahmed Elsayed; Alvaro Avezum; Charles Mondo; Hans-Christoph Diener; Danuta Ryglewicz; Anna Czlonkowska; Nana Pogosova; Christian Weimar; Romaina Iqbal; Rafael Diaz; Khalid Yusoff; Afzalhussein Yusufali; Aytekin Oguz; Xingyu Wang; Ernesto Penaherrera; Fernando Lanas; Okechukwu S Ogah; Adesola Ogunniyi; Helle K Iversen; German Malaga; Zvonko Rumboldt; Shahram Oveisgharan; Fawaz Al Hussain; Daliwonga Magazi; Yongchai Nilanont; John Ferguson; Guillaume Pare; Salim Yusuf
Journal:  Lancet       Date:  2016-07-16       Impact factor: 79.321

2.  China's battle with stroke.

Authors: 
Journal:  Lancet Neurol       Date:  2008-12       Impact factor: 44.182

3.  Associations between serum uric acid levels and the incidence of nonfatal stroke: a nationwide community-based cohort study.

Authors:  Keita Kamei; Tsuneo Konta; Atsushi Hirayama; Kazunobu Ichikawa; Isao Kubota; Shouichi Fujimoto; Kunitoshi Iseki; Toshiki Moriyama; Kunihiro Yamagata; Kazuhiko Tsuruya; Ichiei Narita; Masahide Kondo; Yugo Shibagaki; Masato Kasahara; Koichi Asahi; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2016-07-12       Impact factor: 2.801

4.  Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study.

Authors:  Michiel J Bos; Peter J Koudstaal; Albert Hofman; Jacqueline C M Witteman; Monique M B Breteler
Journal:  Stroke       Date:  2006-05-04       Impact factor: 7.914

Review 5.  Hyperuricemia and incident hypertension: a systematic review and meta-analysis.

Authors:  Peter C Grayson; Seo Young Kim; Michael LaValley; Hyon K Choi
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-01       Impact factor: 4.794

Review 6.  Hyperuricemia and risk of stroke: a systematic review and meta-analysis of prospective studies.

Authors:  Min Li; Wenshang Hou; Xiaowei Zhang; Liqin Hu; Zhenyu Tang
Journal:  Atherosclerosis       Date:  2013-12-01       Impact factor: 5.162

7.  Effect of oestrogen therapy on plasma and urinary levels of uric acid.

Authors:  A Nicholls; M L Snaith; J T Scott
Journal:  Br Med J       Date:  1973-02-24

8.  Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2.

Authors:  John Kanellis; Susumu Watanabe; Jin H Li; Duk Hee Kang; Ping Li; Takahiko Nakagawa; Ann Wamsley; David Sheikh-Hamad; Hui Y Lan; Lili Feng; Richard J Johnson
Journal:  Hypertension       Date:  2003-05-12       Impact factor: 10.190

Review 9.  The large and growing burden of stroke.

Authors:  Seana L Paul; Velandai K Srikanth; Amanda G Thrift
Journal:  Curr Drug Targets       Date:  2007-07       Impact factor: 3.465

Review 10.  The Controversial Role of Homocysteine in Neurology: From Labs to Clinical Practice.

Authors:  Rita Moretti; Paola Caruso
Journal:  Int J Mol Sci       Date:  2019-01-08       Impact factor: 5.923

View more
  1 in total

1.  Uric Acid and Clinical Outcomes in Young Patients with Ischemic Stroke.

Authors:  Yanfang Liu; Xinmin Liu; Jiaokun Jia; Jiahuan Guo; Guangshuo Li; Xingquan Zhao
Journal:  Neuropsychiatr Dis Treat       Date:  2022-09-29       Impact factor: 2.989

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.